BioSpace News Archive

Phreesia, Inc. (“Phreesia”), a leading patient intake management platform, today announced that it has commenced an initial public offering of its common stock.

Cold Spring Harbor Laboratory announced the election of Laura Slatkin to the private, not-for-profit institution’s Board of Trustees.

Median Technologies, The Imaging Phenomics Company® and AG Mednet have renewed their partnership to use AG Mednet’s global infrastructure for the collection, QC and delivery of medical images and ancillary data in support current and future clinical trials and programs.

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that the underwriters of its recently closed underwritten public offering of 7,000,000 ordinary shares have exercised in full their option to purchase an additional 1,050,000 ordinary shares at the public offering price of $5.00 per share.

SaVida Health, a leader in outpatient medication-assisted treatment for opioid and alcohol addiction, will open a new treatment center in Culpeper, Virginia on July 15, 2019.

A white paper from HealthView Services, Why Health Needs to Be Part of Retirement Planning, provides new data detailing the projected cost of healthcare, the impact of health conditions, and strategies to plan for, manage, and even reduce healthcare costs in retirement.

Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has completed the previously announced divestiture of its Animal Health business to PetIQ (NASDAQ: PETQ) for $185 million.

Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its second quarter ended June 30, 2019 after the market closes on Thursday, July 25, 2019

Expansion will further affordable infusion access for patients with chronic diseases

Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), announced today the publication of a study in BMC Biotechnology,